Ginkgo Bioworks is getting ready for another year of disrupting the entire biotech industry model with its versatile menu of biology engineering services. As a full-stack synthetic biology service ...

Protein large language model (LLM) designed to help enterprises accelerate drug development coming to Google Cloud's Vertex AI Model Garden soon; one of the first-of-its-kind in the industry Model API ...

BOSTON — Ginkgo Bioworks, the once-high-flying Boston life sciences firm, on Thursday said it has notified 158 employees that they will be laid off and expects to announce another batch of layoffs ...

Ginkgo Bioworks draws attention as healthcare strength meets caution around synthetic biology, platform growth, and execution ...

Ginkgo Bioworks (NYSE: DNA) went public a few years ago. With sky-high expectations for growth spanning multiple industries, it may have been tempting for investors to take a chance on the ...

For now, that is. Sensible Biotechnologies, a startup based in Bratislava, Slovakia and Oxford in the U.K. has just announced a partnership with Ginkgo Bioworks that might just turn mRNA-based ...

Virica Biotech will provide a panel of their cell enhancers for use in high-throughput AAV production screening for Ginkgo’s clients. Ginkgo Bioworks will leverage their advanced screening platform ...

BOSTON--(BUSINESS WIRE)--Ginkgo Bioworks, an organism design company, today announced that it has raised $45 million in an oversubscribed Series B round. Viking Global, a firm managing more than $30 ...

Adria Cimino: Ginkgo Bioworks has built a cell engineering platform that's attracted a wide range of customers across industries. The company has seen the most growth, though, in the healthcare and ...

Ginkgo's future may be promising, but whether the company can realize its potential is debatable. Special purpose acquisition companies (SPACs) were popular in 2021 while investors were buying up meme ...